Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 12, Pages 3950
Publisher
MDPI AG
Online
2018-12-10
DOI
10.3390/ijms19123950
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2
- (2018) Hui-Ning Liu et al. Archives of Medical Science
- Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways
- (2018) Shuo Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- 8-Chrysoeriol, as a potential BCL-2 inhibitor triggers apoptosis of SW1990 pancreatic cancer cells
- (2018) Yiwen Zhang et al. BIOORGANIC CHEMISTRY
- Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
- (2018) Yunhui Hu et al. CANCER LETTERS
- Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer
- (2018) Jin-Young Lee et al. CANCER LETTERS
- Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signaling
- (2018) Tamara Vervloessem et al. CELL CALCIUM
- Bcl-2 on the brink of breakthroughs in cancer treatment
- (2018) John C Reed CELL DEATH AND DIFFERENTIATION
- Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members
- (2018) Lidia Villanova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective targeting of antiapoptotic BCL-2 proteins in cancer
- (2018) Ahmet Can Timucin et al. MEDICINAL RESEARCH REVIEWS
- The PPARγ agonist rosiglitazone sensitizes the BH3 mimetic (−)-gossypol to induce apoptosis in cancer cells with high level of Bcl-2
- (2018) Xinzhe Li et al. MOLECULAR CARCINOGENESIS
- Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2
- (2018) Xiufen Wang et al. ONCOLOGY RESEARCH
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
- (2018) Xiaomin Meng et al. OncoTargets and Therapy
- Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer
- (2018) Haolong Li et al. Cell Death & Disease
- Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
- (2018) Touko Inao et al. Oncotarget
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo
- (2018) Yi Zhou et al. DIGESTIVE DISEASES AND SCIENCES
- Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
- (2018) Ryan S. Soderquist et al. Nature Communications
- Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy
- (2018) Ryuji Yamaguchi et al. PHARMACOLOGY & THERAPEUTICS
- BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy
- (2018) Adrien Nougarède et al. Oncotarget
- miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
- (2018) Yanqin Sun et al. Cancer Management and Research
- BH3-only protein BIM: An emerging target in chemotherapy
- (2017) Shatrunajay Shukla et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Protein Kinase Targets in Breast Cancer
- (2017) Marilina García-Aranda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells
- (2017) Qianqian Zheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-184 inhibits proliferation and promotes apoptosis of human colon cancer SW480 and HCT116 cells by downregulating C-MYC and BCL-2
- (2017) Yong-Bing Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- BCL-W has a fundamental role in B cell survival and lymphomagenesis
- (2017) Clare M. Adams et al. JOURNAL OF CLINICAL INVESTIGATION
- High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis
- (2017) Qi Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- BCL-XL overexpression promotes tumor progression-associated properties
- (2017) Daniela Trisciuoglio et al. Cell Death & Disease
- BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
- (2016) Fabien Llambi et al. CELL
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
- (2016) Katelyn L. O'Neill et al. GENES & DEVELOPMENT
- BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
- (2016) Mohamed-Amine Hamouda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combining a GSI and BCL-2 inhibitor to overcome melanoma’s resistance to current treatments
- (2016) Nabanita Mukherjee et al. Oncotarget
- Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia
- (2015) R. Pan et al. BLOOD
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- Role of the pro-survival molecule Bfl-1 in melanoma
- (2015) C.K. Hind et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: Potential new target for cancer treatment
- (2014) Edward F. Greenberg et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma
- (2014) V. Fresquet et al. BLOOD
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanism of Action of Immunotherapy
- (2014) Mary L. Disis SEMINARS IN ONCOLOGY
- The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s Disease
- (2014) Carla Loreto et al. Biomed Research International
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Potential utility of the pan-Bcl-2 inhibitor GX15–070 (obatoclax) in cancer immunotherapy
- (2014) Peter S Kim et al. OncoImmunology
- Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis
- (2013) D Westphal et al. CELL DEATH AND DIFFERENTIATION
- Lysosomal cell death at a glance
- (2013) S. Aits et al. JOURNAL OF CELL SCIENCE
- Bcl-2 expression predicts sensitivity to chemotherapy in breast cancer: a systematic review and meta-analysis
- (2013) Dong Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma
- (2012) Y Shao et al. CELL DEATH AND DIFFERENTIATION
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
- (2012) C. Bodur et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the Bcl-2 family for cancer therapy
- (2012) Shibu Thomas et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Lysosomes and lysosomal cathepsins in cell death
- (2011) Urška Repnik et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- BCL2A1: the underdog in the BCL2 family
- (2011) M Vogler CELL DEATH AND DIFFERENTIATION
- The PIDDosome, DNA-damage-induced apoptosis and beyond
- (2011) S Janssens et al. CELL DEATH AND DIFFERENTIATION
- p53 Facilitates BH3-only BID nuclear export to induce apoptosis in the irrepairable DNA damage response
- (2011) Gang Song et al. MEDICAL HYPOTHESES
- Molecular biology of Bax and Bak activation and action
- (2010) Dana Westphal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis
- (2010) F Grespi et al. CELL DEATH AND DIFFERENTIATION
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine
- (2010) Benedetto Farsaci et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Mitochondrial Apoptotic Events by p53-mediated Disruption of Complexes between Antiapoptotic Bcl-2 Members and Bim
- (2010) Jie Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration
- (2010) Christopher C. Howells et al. JOURNAL OF THEORETICAL BIOLOGY
- The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells
- (2010) N Goncharenko-Khaider et al. ONCOGENE
- Bcl2 family proteins in carcinogenesis and the treatment of cancer
- (2009) Anna Frenzel et al. APOPTOSIS
- Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis
- (2009) E N Gurzov et al. CELL DEATH AND DIFFERENTIATION
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes
- (2009) G Chinnadurai et al. ONCOGENE
- Bim and Bmf in tissue homeostasis and malignant disease
- (2009) J D Piñon et al. ONCOGENE
- Noxa: at the tip of the balance between life and death
- (2009) C Ploner et al. ONCOGENE
- The role of HRK gene in human cancer
- (2009) M Nakamura et al. ONCOGENE
- PUMA, a potent killer with or without p53
- (2009) J Yu et al. ONCOGENE
- Immunosensitization with a Bcl-2 small molecule inhibitor
- (2008) Jonathan Begley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Akt Regulates Drug-Induced Cell Death through Bcl-w Downregulation
- (2008) Michela Garofalo et al. PLoS One
- Apoptosis: controlled demolition at the cellular level
- (2007) Rebecca C. Taylor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now